Accuray Inc ARAY.OQ reported quarterly breakeven results per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 3 cents. The mean expectation of four analysts for the quarter was for earnings of 2 cents per share. Wall Street expected results to range from zero cents to 3 cents per share.
Revenue fell 5% to $127.54 million from a year ago; analysts expected $123.77 million.
Accuray Inc's reported EPS for the quarter was 1 cent.
The company reported quarterly net income of $1.12 million.
Accuray Inc shares had risen by 8.0% this quarter and lost 25.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 333.3% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Wall Street's median 12-month price target for Accuray Inc is $4.25, about 65.2% above its last closing price of $1.48
This summary was machine generated from LSEG data August 13 at 09:00 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | 0.02 | 0.00 | Missed |
Mar. 31 2025 | -0.05 | -0.01 | Beat |
Dec. 31 2024 | -0.02 | 0.02 | Beat |
Sep. 30 2024 | -0.05 | -0.04 | Beat |